Information  X 
Enter a valid email address

Sportech PLC (SPO)

  Print          Annual reports

Wednesday 28 July, 2021

Sportech PLC

Admission of Ordinary Shares to trading on AIM

RNS Number : 6165G
Sportech PLC
28 July 2021

28 July 2021


("Sportech", the "Group" or the "Company")


Admission of Ordinary Shares to trading on AIM


Sportech (AIM:SPO), an international betting technology business, announces that further to the Company's announcement on 4 June 2021, the General Meeting held on 29 June 2021 and the Schedule 1 and Schedule 1 Appendix announcements made on 30 June 2021, the Board is pleased to confirm that the admission of the Company's ordinary shares of 20 pence each (the "Ordinary Shares") to trading on AIM occurred at 08.00 a.m. today, 28 July 2021.  Simultaneously, the admission of the Company's Ordinary Shares on the Official List of the Financial Conduct Authority and to trading on the Main Market of London Stock Exchange plc has been cancelled.


The Ordinary Shares will continue to trade under the TIDM "SPO", the LEI and ISIN will also remain the same.


Company information, as required by AIM Rule 26, can be found at


- Ends -





Sportech PLC

Giles Vardey, Chairman

Richard McGuire, Chief Executive Officer

Tom Hearne, Chief Financial Officer


Tel: +44 (0) 117 902 9000

Peel Hunt (Nominated Adviser & Broker)

George Sellar

Andrew Clark

Will Bell


Tel: +44 (0) 20 7418 8900

Buchanan (Financial Communications)

Henry Harrison-Topham

Jamie Hooper

George Beale


Tel: +44 (0) 20 7466 5000

[email protected]



Notes to Editors:


About Sportech

Sportech PLC, an international betting technology business, delivers solutions and services for gaming companies and lottery clients in highly regulated markets. Sportech also owns and operates gaming venues and digital betting platforms in Connecticut under exclusive licences.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t